66
Participants
Start Date
March 7, 2022
Primary Completion Date
September 30, 2025
Study Completion Date
March 31, 2027
Polysiloxane Gd-Chelates based nanoparticles (AGuIX)
Four intravenous injections of AGuIX will be delivered. Phase I : Three dose levels may be explored 50 mg/kg, 75 mg/kg and 100 mg/ kg. Phase II : recommended dose
radiotherapy
60 Gy in 6 weeks
Temozolomide
"Concomitant chemotherapy consists of temozolomide (TMZ) at a dose of 75 mg per square meter per day, given 7 days per week from the first day of radiotherapy until the last day of radiotherapy.~After a 4 week break after concomitant treatment, patient were then received up to 6 cycles of adjuvant TMZ according to the standard 5-day schedule every 28 days ."
Centre Jean Perrin, Clermont-Ferrand
CHU de Brest, Brest
CHU de Grenoble, Grenoble
Centre Léon Berard, Lyon
Hospices Civils de Lyon, Lyon
Hôpital La Pitié Salpetrière, Paris
Institut de Cancérologie de l'Ouest, Saint-Herblain
Institut de Cancérologie Strasbourg Europe, Strasbourg
Institut Gustave Roussy, Villejuif
Ministry for Health and Solidarity, France
OTHER_GOV
Centre Jean Perrin
OTHER